Results 11 to 20 of about 114,322 (384)

Prevalence and factors associated with polypharmacy: a systematic review and Meta-analysis

open access: yesBMC Geriatrics, 2022
Introduction Polypharmacy is commonly associated with adverse health outcomes. There are currently no meta-analyses of the prevalence of polypharmacy or factors associated with polypharmacy.
Mahin Delara   +7 more
doaj   +2 more sources

What is polypharmacy? A systematic review of definitions

open access: yesBMC Geriatrics, 2017
Background Multimorbidity and the associated use of multiple medicines (polypharmacy), is common in the older population. Despite this, there is no consensus definition for polypharmacy.
Nashwa Masnoon   +3 more
doaj   +2 more sources

Aging and the Prevalence of Polypharmacy and Hyper-Polypharmacy Among Older Adults in South Korea: A National Retrospective Study During 2010–2019

open access: yesFrontiers in Pharmacology, 2022
Background: Polypharmacy has become a global health problem and is associated with adverse health outcomes in the elderly. This study evaluated the prevalence of polypharmacy and hyper-polypharmacy in elderly patients in South Korea during 2010–2019 ...
Ho Jin Cho   +3 more
doaj   +2 more sources

Medication use patterns and polypharmacy among elderly in Iran: a cross-sectional study using national health insurance claims data [PDF]

open access: yesBMJ Open
Objectives Polypharmacy, defined as the concurrent use of multiple medications, is a growing concern among the elderly, especially in low-income and middle-income countries such as Iran.
Sepehr Khosravi   +9 more
doaj   +2 more sources

Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016.

open access: yesPLoS ONE, 2021
Background/objectivesWith an aging population suffering from increased prevalence of chronic conditions in the United States (U.S.), a large portion of these patients are on multiple medications.
Eric H Young   +4 more
doaj   +2 more sources

An overview of prevalence, determinants and health outcomes of polypharmacy

open access: yesTherapeutic Advances in Drug Safety, 2020
A high rate of polypharmacy is, in part, a consequence of the increasing proportion of multimorbidity in the ageing population worldwide. Our understanding of the potential harm of taking multiple medications in an older, multi-morbid population, who are
Mina Khezrian   +3 more
doaj   +2 more sources

Polypharmacy in the elderly

open access: yesJournal of Research in Pharmacy Practice, 2015
Objective: The objective was to assess the frequency of polypharmacy and potential complications among local seniors. Methods: A cross-sectional convenience sample of 59 adults aged above 65 years was interviewed at Cuyahoga county (U.S.
Negar Golchin   +4 more
doaj   +4 more sources

Polypharmacy [PDF]

open access: yesJAMA, 2017
na
Onder, Graziano, Marengoni, Alessandra
openaire   +4 more sources

Polypharmacy trajectories among older women with and without dementia: A longitudinal cohort study

open access: yesExploratory Research in Clinical and Social Pharmacy, 2021
Background: Although multiple medications are often utilized to achieve optimal treatment outcomes, polypharmacy (use of five or more medications) among older population is associated with several detrimental effects.
Kailash Thapaliya   +2 more
doaj   +1 more source

Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences

open access: yesEuropean Geriatric Medicine, 2021
This narrative review aims to find and summarize recent publications on definitions, epidemiology and clinical consequences of polypharmacy. Numerous definitions of polypharmacy and associated terms were found.
F. Pazan, M. Wehling
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy